Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azacitidine in Acute Myeloid Leukemia
NCT01180322Phase 2Completed
- Sponsor
- Ulm University
- Start
- Nov 2010
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of azacitidine in acute myeloid leukemia (AML), sponsored by Ulm University. Started Nov 2010; status: completed.
02
Drugs
azacitidine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01180322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01180322.